Repeat Diagnostics
Repeat Diagnostics (RepeatDx) is a privately held clinical laboratory specializing in telomere length testing using proprietary Flow FISH technology, serving physicians and hospitals worldwide for diagnosis of dyskeratosis congenita, pulmonary fibrosis, bone marrow failure syndromes, and transplant donor screening.
- Company typePrivate
- Founded2005
- HeadquartersNorth Vancouver, Canada
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Repeat Diagnostics does
Repeat Diagnostics Inc (RepeatDx) is a privately held clinical diagnostic laboratory headquartered in North Vancouver, British Columbia, Canada, with a secondary European office in Aachen, Germany. Founded in 2005, the company specializes exclusively in clinical telomere length testing using proprietary Flow FISH (Flow Fluorescence In Situ Hybridization) technology, which was developed and perfected by co-founder Peter Lansdorp and his team at the BC Cancer Agency's Terry Fox Laboratory. RepeatDx is the only clinical laboratory accredited to provide telomere length analysis in all 50 US States and Territories under CLIA certification, with additional licensing in Canada (BC DAP program), Europe (ISO 9001), and multiple US states (California, New York, Rhode Island, Pennsylvania, Maryland).
The company's core product is a clinical testing service that measures telomere length across six cell types in peripheral blood (lymphocytes, granulocytes, T-cells, B-cells, and NK cells), using an age-adapted reference database built from over 800 healthy subjects aged 0-100 years. Testing services address dyskeratosis congenita, pulmonary fibrosis, bone marrow failure syndromes, myelodysplastic syndromes, acute myeloid leukemia, liver failure, and bone marrow/stem cell transplant donor screening. Tests are ordered exclusively by licensed physicians through the company's website, samples are shipped to the laboratory for analysis, and results are returned to the ordering physician. RepeatDx does not bill insurance directly; billing is sent to the medical institution or patient.
Revenue is generated through one-time per-test fees (pricing not publicly disclosed). The go-to-market is sales-led and physician-direct, supported by content marketing (website, blog, social media on Facebook/Twitter/YouTube/Instagram), medical conference participation (e.g., Marrow Failure and Myelodysplasia Patient and Family Conference), and partnerships with Team Telomere (patient advocacy) and academic institutions (BC Cancer Agency, Uniklinik RWTH Aachen). Leadership comprises Peter Lansdorp (CSO), Geraldine Aubert (Director of Clinical Development & Research since 2011), Audi Setiadi (Medical Director, appointed 2025), Fabian Beier (Medical Advisor Europe since 2015), and Elmira Hariri. The company is privately held with no disclosed funding rounds, parent company, or M&A activity.
Repeat Diagnostics firmographics
Firmographics- Name
- Repeat Diagnostics
- Legal name
- Repeat Diagnostics Inc
- Website
- https://repeatdx.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Repeat Diagnostics (RepeatDx) is a privately held clinical laboratory specializing in telomere length testing using proprietary Flow FISH technology, serving physicians and hospitals worldwide for diagnosis of dyskeratosis congenita, pulmonary fibrosis, bone marrow failure syndromes, and transplant donor screening.
- Ownership category
- akta.pro rank
Repeat Diagnostics industry classification
Industry- Product category
- Clinical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Companion Diagnostics (CDx) & Therapy Selection Assays (HLAAALAF)
- akta.pro secondary industries
- Companion Diagnostics (CDx) Development & Commercialization (HLAAANAC), Companion Diagnostics (CDx) & Precision Medicine IVD (HLAHAAAJ), Companion Diagnostics (CDx) Development & Trial Testing Support (HLAGAEAJ)
Keywords
Where Repeat Diagnostics is headquartered
LocationHeadquarters
- HQ city
- North Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Repeat Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Telomere Testing Services: RepeatDx provides specialized clinical telomere length testing services to physicians and hospitals. Testing is ordered by licensed medical doctors for patients with suspected telomere biology disorders, bone marrow failure syndromes, pulmonary fibrosis, and for donor selection prior to bone marrow or stem cell transplantation. The company sends test billing to the medical institution requesting the test or to the patient.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Repeat Diagnostics product offering
Product offeringCore offering
Repeat Diagnostics (RepeatDx) is a clinical diagnostic laboratory that performs Flow FISH telomere length analysis on peripheral blood samples for licensed physicians and hospitals. The laboratory measures telomere length across six cell types and provides diagnostic information for telomere biology disorders including dyskeratosis congenita, pulmonary fibrosis, and bone marrow failure syndromes, and supports donor selection screening prior to bone marrow or stem cell transplantation.
Product overview
RepeatDx is a clinical diagnostic laboratory specializing in telomere length testing services using proprietary Flow FISH technology. The company operates as a single-product clinical laboratory offering telomere length analysis, with the core Flow FISH platform measuring telomere length across six cell types in peripheral blood. Testing services cover diagnostic applications for dyskeratosis congenita, pulmonary fibrosis, bone marrow failure syndromes, myelodysplastic syndromes, acute myeloid leukemia, liver failure, and stem cell donor screening. The company has been operating since 2005 and is the only clinical laboratory accredited to provide Telomere Length Analysis in all 50 US States and Territories.
Differentiator
Problem solved
Functional benefit
Products and services
- RepeatDx Telomere Length Testing Clinical Flow FISH telomere length analysis service that measures telomere length in six cell types from peripheral blood samples (lymphocytes, granulocytes, T-cells, B-cells, and NK-cells), providing diagnostic information for telomere biology disorders including dyskeratosis congenita, pulmonary fibrosis, and bone marrow failure syndromes. Tests are ordered by licensed medical doctors and processed at the RepeatDx clinical laboratory in North Vancouver, BC.
- Flow FISH Technology Platform Proprietary flow cytometry-based fluorescence in situ hybridization (Flow FISH) technology used to measure telomere length at the individual cell level, offering higher accuracy, sensitivity, and specificity compared with qPCR methods. Published in Nature Protocols in 2006 by Peter Lansdorp and colleagues at the BC Cancer Agency Terry Fox Laboratory.
- Dyskeratosis Congenita Telomere Testing Specialized telomere length analysis with established clinical sensitivity and specificity for diagnosing dyskeratosis congenita (DC), an inherited bone marrow failure syndrome categorized as a telomere biology disorder. Used by physicians to support diagnostic and prognostic decisions for DC and related conditions.
- Pulmonary Fibrosis Telomere Testing Telomere length analysis service used for the diagnosis of familial and idiopathic pulmonary fibrosis, disease course prediction, transplant-free survival assessment, and post-transplant immunosuppression guidance. Leukocyte telomere length has been identified as an independent predictor of disease progression in pulmonary fibrosis.
- Bone Marrow Donor Screening Telomere length testing service for stem cell donor selection prior to bone marrow or stem cell transplantation, intended to identify donors with healthy telomere maintenance. Used by physicians as part of donor selection screening workflows.
Quantifiable outcome
- Flow FISH is more accurate, reproducible, sensitive, and specific in measurement of human leukocyte telomere length compared to qPCR (peer-reviewed study published in PLOS ONE)
Companies that use Repeat Diagnostics
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
Repeat Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Repeat Diagnostics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and regional.
- Team TelomerecoreTeam Telomere is a patient advocacy organization for individuals and families affected by telomere biology disorders. RepeatDx partners with Team Telomere to support awareness and education. Team Telomere published the Telomere Biology Disorders: Diagnosis and Management Guidelines, a comprehensive reference manual for patients, physicians, and researchers.
- BC Cancer Agency (Terry Fox Laboratory)corePeter Lansdorp and his research team at the BC Cancer Agency Terry Fox Laboratory developed and perfected the Flow FISH procedure. This knowledge and technology were successfully translated to licensed and validated clinical testing service with RepeatDx. Geraldine Aubert is also a Staff Scientist at the BC Cancer Agency Terry Fox Laboratory.
- Uniklinik RWTH AachenregionalUniversity hospital in Aachen, Germany that serves as RepeatDx's European partner. The Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation (SZT) collaborates with RepeatDx for European operations. Dr. Fabian Beier serves as Medical Advisor Europe from this location.
Scale indicators4 records
Recent moves4 records
Expansion highlights5 records
Repeat Diagnostics competitors and assessment
Company assessmentBroad incumbents
- Sonic Healthcare: International pathology and clinical laboratory services provider with specialty testing capabilities. Relevant as a global reference-lab peer with multi-jurisdiction regulatory footprint analogous to RepeatDx's US/Canada/Europe licensing.
- Quest Diagnostics: Largest US clinical laboratory offering a broad menu including telomere length testing. Competes on reach and insurance integration but lacks RepeatDx's specialist positioning in telomere biology disorders.
- Laboratory Corporation of America (LabCorp): Major national reference laboratory offering telomere length testing among many specialty diagnostics. Competes via scale and integrated billing rather than scientific specialization in telomere biology.
Direct peers
- Mayo Clinic Laboratories: Major US reference laboratory that offers telomere length testing as part of its specialty diagnostics menu. Direct competitor in the telomere testing niche, with the advantage of in-network insurance billing and broader hospital relationships.
- Johns Hopkins Genomics: Academic medical genetics laboratory offering telomere-related diagnostic testing for dyskeratosis congenita and related disorders. Comparable academic-affiliated specialty diagnostics model with research-to-clinical translation.
- ARUP Laboratories: University-affiliated reference laboratory offering specialized genetic and molecular diagnostics including telomere length testing for telomere biology disorders. Comparable niche specialty testing model with academic hospital ties.
Others
- Team Telomere: Patient advocacy organization and RepeatDx's named partner; not a commercial peer but the leading ecosystem organization in telomere biology disorders and the publisher of diagnosis/management guidelines that shape physician referral patterns.
- BC Cancer Agency / Terry Fox Laboratory: Research institution where the Flow FISH technology was originally developed and RepeatDx's co-founder remains a Distinguished Scientist. Functions as RepeatDx's R&D partner rather than a commercial peer, but shapes the technology roadmap.
Emerging players
- SpectraCell Laboratories: Specialty clinical laboratory offering telomere length testing alongside micronutrient and cardiometabolic diagnostics. Comparable specialty-lab model targeting niche clinical biomarkers.
- Life Length: Spain-based specialty telomere diagnostics company offering TAT (Telomere Analysis Technology) for clinical and research applications. Closest technology-adjacent peer competing in the same telomere measurement niche from outside North America.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Repeat Diagnostics social profiles
Digital presenceRepeat Diagnostics compliance and trust
Trust signalCompliance5 records
Repeat Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Repeat Diagnostics leadership team
Management profileNumber of profiles
Profiles5 records
Repeat Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Repeat Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Repeat Diagnostics
What does Repeat Diagnostics do?
Repeat Diagnostics (RepeatDx) is a clinical diagnostic laboratory that performs Flow FISH telomere length analysis on peripheral blood samples for licensed physicians and hospitals. The laboratory measures telomere length across six cell types and provides diagnostic information for telomere biology disorders including dyskeratosis congenita, pulmonary fibrosis, and bone marrow failure syndromes, and supports donor selection screening prior to bone marrow or stem cell transplantation.
Is Repeat Diagnostics a public or private company?
Repeat Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Repeat Diagnostics founded?
Repeat Diagnostics was founded in 2005. It employs 1 to 10 people.
Where is Repeat Diagnostics based?
Repeat Diagnostics is headquartered in North Vancouver, Canada, in the North America region.
How does Repeat Diagnostics make money?
One revenue line is on record: clinical Telomere Testing Services.
Who are Repeat Diagnostics's main competitors?
Broad incumbents on record are Sonic Healthcare, Quest Diagnostics and Laboratory Corporation of America (LabCorp). Direct peers are Mayo Clinic Laboratories, Johns Hopkins Genomics and ARUP Laboratories. Others are Team Telomere and BC Cancer Agency / Terry Fox Laboratory. Emerging players are SpectraCell Laboratories and Life Length.
Does Repeat Diagnostics have an API?
No public API is recorded for Repeat Diagnostics.
What industry is Repeat Diagnostics in?
Repeat Diagnostics's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAAALAF, Companion Diagnostics (CDx) & Therapy Selection Assays, with a secondary code of HLAAANAC, Companion Diagnostics (CDx) Development & Commercialization. Its NAICS code is 621511 and its SIC code is 8071.